The California Institute for Regenerative Medicine (CIRM), a state agency with a US$3-billion budget for stem-cell research, is in need of more funding. Nature reports that “CIRM had to revamp its structure and practices in response to complaints about inefficiency and potential conflicts of interest. It has also had to adapt its mission to seismic
